arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Moderna, Inc.

MRNA

$234.38 ▼ -23.32 (-9.05%) at close

11 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Moderna, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $91.2B

Dividend Yield —

Revenue Growth -39.9% ↗

Op. Margin -158.1% ↘

ROIC -33.9% ↗

FCF / Share $-5.31 ↗

Trailing P/E —

Price / Book 10.7x

FCF Yield —

Debt / Equity 0.07

info Valuation on last close. End-of-day price, Nov 5, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.94B

↓ -39.9% —

Net Income Profit after all expenses

$-2.82B

↑ +20.8% —

Operating Margin Operating profit as % of sales

-158.1%

↓ -29.7% 1th

FCF / Share Free cash flow per share

$-5.31

↑ +49.7% —

Long-Term Debt Long-term obligations

$590.00M

— —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	-39.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-599%)	-52.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-759%)	-64.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-906%)	4.3% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-46%)	2200.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+27403%)	1233.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15321%)	-55.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-793%)	-34.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-530%)	89.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1024%)	—	—
EPS Growth YoY (%)	21.8% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	24.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	-29.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	20.8% Good ↑ Good Improving Year-over-year change in net income	24.5% Good Good Year-over-year change in net income	N/M	-31.5% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-45.3% Weak ↓ Weak Declining Year-over-year change in net income	-33.6% Weak → Weak Stable Year-over-year change in net income	-50.3% Weak Weak Year-over-year change in net income	-18.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	49.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-5.5% Weak ↓ Weak Declining Year-over-year change in free cash flow	N/M	-64.9% Weak Weak Year-over-year change in free cash flow	543.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-53.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-44.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	104.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	583.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	415.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	57.4% Excellent Excellent Compound annual revenue growth over 3 years	-17.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	19.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	121.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	119.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	147.9% Excellent Excellent Compound annual revenue growth over 5 years	179.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	-158.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1154%)	-121.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-913%)	-61.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-513%)	48.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+226%)	72.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+380%)	-95.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-733%)	—	-306.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2140%)	-130.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-972%)	-206.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1476%)	—
Effective Tax Rate (%) (%)	-2.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-19.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—
Profit Margin (%) (%)	-145.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1310%)	-110.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1017%)	-68.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-674%)	43.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+262%)	66.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+451%)	-93.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-875%)	—	-284.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2474%)	-124.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1136%)	-199.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1762%)	—
FCF Margin (%) (%)	-106.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-125.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-55.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	23.8% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	72.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	244.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-323.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-189.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	31.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-2.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.52x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-33.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	43.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	86.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	38.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	52.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-24.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	36.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	53.9% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-24.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-32.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-32.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-318%)	-34.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-327%)	43.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+192%)	86.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+475%)	-29.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-294%)	-43.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-392%)	-25.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	46.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+209%)	64.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+331%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-307.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-164.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-108.69x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	376.80x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	949.71x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-84.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-137.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-2.00B	$-1.93B	$-2.91B	$-3.21B	$-6.85B	$-2.62B	$-235.88M	$-658.36M	$-134.86M	$-50.08M	$-159.04M
Debt / EBITDA (x)	-0.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$5.00	$8.43	$17.93	$48.89	$45.83	$2.11	—	—	—	—	—
Basic EPS, GAAP (USD)	$-7.26	$-9.28	$-12.33	$21.26	$30.31	$-1.96	—	—	—	—	—
Free Cash Flow per Share (USD)	$-5.31	$-10.56	$-10.01	$11.63	$33.09	$5.14	—	—	—	—	—
Book Value per Share (USD)	$21.95	$28.24	$36.27	$49.67	$35.10	$6.42	$3.49	$4.65	$-8.46	—	—
Tangible Book Value per Share (USD)	$21.82	$28.11	$36.13	$49.67	$35.10	$6.42	$3.49	$4.65	$-8.46	—	—
Basic Weighted Avg Shares (shares)	389.00M	384.00M	382.00M	394.00M	403.00M	381.00M	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$4.56B	$5.89B	$7.31B	$8.51B	$6.94B	$1.91B	$985.69M	$1.34B	$591.76M	—	—
LT Debt (USD)	$590.00M	$0.00	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$8.65B	$10.90B	$13.85B	$19.12B	$14.14B	$2.56B	$1.17B	$1.53B	$-551.37M	$-334.81M	$-149.76M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$1.94B	$3.24B	$6.85B	$19.26B	$18.47B	$803.00M	$60.21M	$135.07M	$205.82M	$108.40M	—
Depreciation Expense (USD)	$211.00M	$185.00M	$617.00M	—	$232.00M	$31.00M	$31.02M	$24.86M	$20.54M	$15.11M	—
Net Income, GAAP (USD)	$-2.82B	$-3.56B	$-4.71B	$8.36B	$12.20B	$-747.00M	$-514.02M	$-384.73M	$-255.92M	$-216.21M	—
Operating Cash Flow (USD)	$-1.87B	$-3.00B	$-3.12B	$4.98B	$13.62B	$2.03B	$-458.97M	$-330.87M	$-331.48M	$66.73M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 11 years · 37 quarters

Moderna, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare MRNA with peers